Seres Therapeutics, Inc.
MCRB
$4.54
$0.061.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.59M | 29.83M | 45.77M | 47.64M | 45.38M |
| Total Receivables | 25.27M | 233.00K | 517.00K | 830.00K | 1.16M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.48M | 1.77M | 3.09M | 3.06M | 2.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 42.35M | 31.84M | 49.38M | 51.53M | 48.69M |
|
|
|||||
| Total Current Assets | 42.35M | 31.84M | 49.38M | 51.53M | 48.69M |
| Net Property, Plant & Equipment | 56.97M | 77.08M | 80.12M | 83.25M | 86.42M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.27M | 8.70M | 8.70M | 8.70M | 8.70M |
| Total Assets | 101.59M | 117.62M | 138.19M | 143.47M | 143.80M |
|
|
|||||
| Total Accounts Payable | 1.19M | 2.34M | 1.68M | 1.68M | 2.20M |
| Total Accrued Expenses | 3.74M | 2.86M | 3.97M | 6.38M | 5.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.83M | 10.87M | 10.39M | 9.92M | 9.48M |
| Total Finance Division Other Current Liabilities | 3.28M | 3.28M | 3.28M | 4.45M | 13.45M |
| Total Other Current Liabilities | 3.28M | 3.28M | 3.28M | 4.45M | 13.45M |
| Total Current Liabilities | 20.03M | 19.34M | 19.32M | 22.43M | 30.94M |
|
|
|||||
| Total Current Liabilities | 20.03M | 19.34M | 19.32M | 22.43M | 30.94M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.82M | 69.63M | 72.58M | 75.33M | 77.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.21M | 2.14M | 2.08M | 2.01M | 1.95M |
| Total Liabilities | 67.05M | 91.12M | 93.98M | 99.78M | 110.85M |
|
|
|||||
| Common Stock & APIC | 1.02B | 1.02B | 1.02B | 1.00B | 998.22M |
| Retained Earnings | -987.74M | -992.32M | -972.40M | -957.07M | -965.27M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 34.53M | 26.50M | 44.22M | 43.70M | 32.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.53M | 26.50M | 44.22M | 43.70M | 32.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.53M | 26.50M | 44.22M | 43.70M | 32.95M |
|
|
|||||